跳至主要内容
临床试验/NL-OMON35815
NL-OMON35815招募中不适用

Clozapine in Daily Life: an Experience Sampling Pilot Study - Clozapine in Daily Life

Academisch Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Eligible for the study are in- and outpatients age 18 to 60, meeting DSM-IV criteria for schizophrenia, schizoaffective or schizophreniform disorder starting treatment with clozapine.
  • Patients that are admitted under authority of the court should also be included, since this group embodies a part of the target group.
  • Patients should be able to understand the study information and procedures and give informed consent.

排除标准

  • - Pregnancy
  • - Lactating women
  • - Female subject without adequate contraception
  • - Known hypersensitivity to clozapine or ingredients used in these tablets
  • - Narrow-angle glaucoma
  • - Known neurological or endocrine disease interfering with clozapine treatment
  • - Myeloproliferative disorder
  • - Uncontrolled epilepsy
  • - Paralytic ileus
  • - Current leukocyte level lower than 3.5 x 109/l
  • - Current neutrophilic granulocyte level lower than 2.0x 109/l
  • -Use of: fluvoxamine, carbamazepine, coumarine derivates, cimetidine, ciprofloxacine, erythromycine, citalopram and cytostatica

研究者

相似试验